towards precision medicine in - medinews.it · dott.a.m.grimaldi@gmail.com napoli francesco...

Post on 14-Feb-2019

213 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

MEDITERRANEAN SCHOOL OF ONCOLOGYwww.mso.cinbo.org

DIRECTORClara Natoli

SCIENTIFIC SECRETARIATConsiglia CarellaMichele De Tursi

Antonino GrassadoniaNicola Tinari

SCIENTIFIC ADVISORY BOARDVincenzo AdamoBarbara BarboniRoberto BiancoGiovanni Brandi

Marco CariniLeonardo Della Salda

Corrado FicorellaFrancesco Grignani

Lorenzo Lo MuzioPatrizia QuerzoliAntonio Russo

Marina ScarpelliSilverio Tomao

Giuseppe Tonini

ORGANIZING SECRETARIATGiovanna Di Credico

OFFICESConsorzio Interuniversitario Nazionale

per la Bio-Oncologia (CINBO)c/o Sezione di Oncologia Medica

Università G. D’Annunzio - Via dei Vestini, 3166100 Chieti - Italy

Phone: +39 0871 3556732Fax +39 0871 3556707

cinbo@unich.it

PROVIDER ECM ID. 50Strategie S.r.L. - Via Piave 110/7 - Pescara

Phone: 085 74143 - Fax: 085 378220info@strategieonweb.itwww.strategieonweb.it

Consorzio Interuniversitario Nazionale per la Bio-Oncologia

presents

TOWARDS PRECISION MEDICINE IN CANCER TREATMENT

May 26, 2017Auditorium c/o RettoratoUniversità degli Studi “G. D’Annunzio”Via dei Vestini, 31Chieti

DirectorsPaolo Marchetti & Clara Natolim

so.c

inb

o.o

rg

CINBOConsorzio Interuniversitario Nazionaleper la Bio-Oncologia

Evento n. ECM 50-190187 per Medici Chirurghi specialisti in: ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; DERMATOLOGIA EVENEREOLOGIA; EMATOLOGIA; ENDOCRINOLOGIA; GENETICAMEDICA; MALATTIE DELL’APPARATO RESPIRATORIO; MEDICINA

INTERNA; NEFROLOGIA; ONCOLOGIA; RADIOTERAPIA; CHIRURGIAGENERALE; CHIRURGIA PLASTICA E RICOSTRUTTIVA; CHIRURGIA

TORACICA; GINECOLOGIA E OSTETRICIA; UROLOGIA; ANATOMIAPATOLOGICA; FARMACOLOGIA E TOSSICOLOGIA CLINICA;

MEDICINA NUCLEARE; PATOLOGIA CLINICA (LABORATORIO DIANALISI CHIMICOCLINICHE E MICROBIOLOGIA);

RADIODIAGNOSTICA; IGIENE, EPIDEMIOLOGIA E SANITÀPUBBLICA; CURE PALLIATIVE; EPIDEMIOLOGIA;

per Farmacisti (Farmacia Ospedaliera); per (Farmacia Ospedaliera); per Biologi

Crediti ECM: 6

si ringrazia per il contributo incondizionato:

La partecipazione è gratuita. Le iscrizioni si accettano esclusivamente on line sul sito del Provider www.strategieonweb.it - pagina ECM 2017

Con il patrocino di:

9.00 Registration & Wellcome coffee9.30 Opening Paolo Marchetti & Clara Natoli

Chair: Amedeo Pancotti and Nicola Tinari 09.50 The near future: P4 Medicine Saverio Alberti 10.10 Precision medicine-based clinical trials Clara Natoli 10.20 The impact of next-generation sequencing on precision medicine Antonio Marchetti 10.40 Discussion leaders Francesco Grignani & Paolo Marchetti

Coffee break

Chair: Teresa Martino and Lucio Laudadio11.40 Molecular subtypes of colorectal cancer: applications in diagnosis and treatment Mario Scartozzi 12.00 Genomic profi ling of prostate, colon and ovarian cancer: ready for prime? Daniele Zanoni12.20 Discussion leaders Corrado Ficorella & Giovanni Brandi 12.40 Lecture Cancer immunotherapy and precision medicine Marianna Nuti

Light Lunch

Chair: Katia Cannita and Luciana Irtelli14.30 ALK and ROS1 kinase inhibitors: molecular mechanisms of resistance Rita Chiari 14.50 MET receptor inhibition in solid tumors Roberto Bianco 15.10 Discussion leaders Riccardo Giampieri & Mario Roselli

Chair: Michele De Tursi and Luca Cindolo15.30 Targeting castration-resistant prostate cancer Arcangelo Sebastianelli15.50 BRAF and MEK inhibitors Antonio Grimaldi16.10 Discussion leaders Silverio Tomao & Vincenzo Adamo

Coffee break

Chair: Antonino Grassadonia and Consiglia Carella16.45 DNA Repair pathways as targets for cancer therapy Domenica Lorusso17:05 Biological and clinical impact of cancer stem cells in ovarian cancer Federica Tomao17.25 RANK as a therapeutic target in cancer Francesco Pantano

17.45 Discussion leaders Giuseppe Tonini & Matteo Landriscina18:05 Conclusions Paolo Marchetti & Clara Natoli

18.15 ECM18.15 ECM

Program Faculty Vincenzo Adamovadamo@unime.itMessina

Saverio Albertis.alberti@unich.itChieti

Roberto Biancorobianco@unina.itNapoli

Giovanni Brandigiovanni.brandi@unibo.itBologna

Katia Cannitakcannita@gmail.comL’Aquila

Consiglia Carellaliacarella@tiscali.itConsiglia Carellaliacarella@tiscali.itConsiglia Carella

Chieti

Rita Chiariritachiar@gmail.comPerugia

Luca Cindololucacindolo@virgilio.itChieti

Michele De Tursidetursi@unich.itChieti

Corrado Ficorellacorrado.fi corella@univaq.itL’Aquila

Riccardo Giampieri riccardo.giampieri81@gmail.comAncona

Antonino Grassadoniagrassadonia@unich.itChieti

Antonio Grimaldidott.a.m.grimaldi@gmail.comNapoli

Francesco Grignanifrancesco.grignani@unipg.itFrancesco Grignanifrancesco.grignani@unipg.itFrancesco Grignani

Perugia

Matteo Landriscinamatteo.landriscina@unifg.itFoggia

Lucio Laudadiolaudadio@oncologialanciano.itLanciano

Domenica Lorussodomenica.lorusso@istitutotumori.mi.itMilano

Luciana Irtelliluciana.irtelli@tiscali.itChieti

Antonio Marchettiantonio.marchetti@unich.itChieti

Paolo Marchettipaolo.marchetti@hotmail.itRoma

Maria Teresa Martinomtmartino@virgilio.itChieti

Clara Natolinatoli@unich.itChieti

Marianna Nutimarianna.nuti@uniroma1.itRoma

Amedeo Pancotti panamedeo@libero.itTeramo

Francesco PantanoF.Pantano@unicampus.itRoma

Mario Rosellimario.roselli@uniroma2.itRoma

Mario Scartozzimarioscartozzi@gmail.comMonserrato Cagliari

Arcangelo Sebastianelliarcangelo.sebastianelli@gmail.comArcangelo Sebastianelliarcangelo.sebastianelli@gmail.comArcangelo Sebastianelli

Firenze

Nicola Tinarintinari@unich.itChieti

Federica Tomaofederica.tomao@uniroma1.itRoma

Silverio Tomaosilverio.tomao@uniroma1.itRoma

Giuseppe Toninig.tonini@unicampus.itRoma

Daniele Zanonid.zanoni83@gmail.comCremona

9.00 Registration & Wellcome coffee9.30 Opening

09.50 The near future: P4 Medicine 10.10 Precision medicine-based clinical trials 10.20 The impact of next-generation sequencing on precision medicine 10.40 Discussion leaders

11.00

11.40 Molecular subtypes of colorectal cancer: applications in diagnosis and treatment 12.00 Genomic profi ling of prostate, colon and ovarian cancer: ready for prime? 12.20 Discussion leaders 12.40 Lecture

13.30

14.30 ALK and ROS1 kinase inhibitors: molecular mechanisms of resistance 14.50 MET receptor inhibition in solid tumors 15.10 Discussion leaders

16.30

15.30 Targeting castration-resistant prostate cancer 15.50 BRAF and MEK inhibitors 16.10 Discussion leaders

16.45 DNA Repair pathways as targets for cancer therapy 17:05 Biological and clinical impact of cancer stem cells in ovarian cancer 17.25 RANK as a therapeutic target in cancer

17.45 Discussion leaders 18:05 Conclusions

18.15 ECM18.15 ECM

top related